AICC Welcomes the Israeli Companies Attending BIO in Atlanta

May 15, 2009

Nineteen Israeli biopharma companies will be in the official delegation to the international BIO conference in Atlanta next week. The Medical Committee of the American-Israel Chamber of Commerce, Southeast Region is partnering with industry and economic development groups from Israel and the Southeast on a special event to welcome them on May 18th. 

Dr. Eli Opper, Chief Scientist of Israel’s Ministry of Industry, Trade & Labor will be the event’s keynote speaker. Dr. Eric Tomlinson, CEO of Atlanta-based Altea Therapeutics will share information about Georgia’s life science community to the Israeli companies in his capacity as Co-chair of the Board of Georgia BIO.

“We’re pleased for this extraordinary opportunity to show hospitality to our industry colleagues from Israel and help make this global event a success for them,” said Charlie Harrison, president of Wynden Pharmaceuticals who chairs the Chamber’s Medical Committee and serves as chairman-elect of AICC’s board.

Aposense Ltd.® (formerly NST) is a clinical stage molecular imaging and drug development company. A pipeline of products based on its patented platform technology for targeting apoptosis (programmed cell death) in vivo. The Aposense® compounds perform selective uptake and accumulation within the apoptotic cells form the early stages of the death process. Successfully evaluated in clinical trials and available for non-exclusive licensing

Core Dynamics brings science fiction to life with innovative freezing, thawing and freeze drying technologies for cell, tissue and organ preservation. Clinical applications of this unique technology are already being used in cartilage repair procedures for knee injuries.

Consortium Bereshith for Cell Therapy – The Israeli consortium for cell and stem cell therapy was originated by companies and the Ministry of Industry, Trade and Labour. The aim of the initiative is to unite academia & industry to develop new technologies.

Do –Coop Technologies, Ltdis a private company based in Israel. Do-Coop was formed in 1997 in order to develop and commercialize novel water-based materials using Nanotechnology for the biotechnology, pharmaceutical and chemical industries as well as additional industries.

Foamix Ltdis a drug development company, specializing in dermatologic and other topical products. While developing our own products, they cooperate with pharmaceutical companies in developing other products, containing their specific drugs and cosmetic active agents.

Hadasit Bio-Holdings Ltd.(“HBL”) was founded in order to allow public participation in the highly promising field of biotechnology. For the first time, public investment is allowed to participate in a holding entity including companies based on IP generated by Israel’s foremost medical research center – Hadassah University Hospital (“HU”). In addition to the public holdings (33%) – including major Israeli institutional investors, HBL is held by Hadasit (www.hadasit.co.il). The traded stock, as a unique investment vehicle, provides investment exposure to a select cluster of 9 biotech companies – all based on inventions developed and owned by HU.

The Haifa Life Science Park – IsraelHaifa Economic Corporation Ltd. is a corporation fully owned by the Municipality of Haifa, operated as an independent business entity. The corporation was established in 1972 by the Municipality of Haifa as a business corporation for the development of Haifa. Since its establishment, it has promoted city development, while initiating and building projects in the fields of environment, infrastructure and productive businesses.

HealOrHealOr, a privately owned company founded in 2002, focuses on development (regulatory driven) and marketing of innovative topical therapeutics for dermal skin pathologies. The company brings up a novel approach for the curing wounds and skin disorders.

ITTNThe Israel Tech Transfer Organization (ITTN) serves as the umbrella organization for Israel’s technology transfer companies. These companies are affiliated with the country’s world-renowned universities and research institutions. Currently, the 12 partnering organizations comprise the shareholders. ITTN intends to add more members from Israel’s government-owned medical centers and research institutions. ITTN is a private non-profit organization.

KAHR Medical‘s technology and IP, is the result of breakthrough discoveries by Professor Mark L. Tykocinski and by his research team at the University of Pennsylvania. This team, together with research teams at Hadassah Medical Center have spent the last 8 years developing novel genetically engineered fusion proteins that have great immuno-therapeutic potential for a wide variety of autoimmune diseases.

Modigene Inc is a publicly traded biopharmaceutical company utilizing patented technology to develop longer-lasting, proprietary versions of already approved therapeutic proteins. Company focus on approved proteins with established safety and efficacy records.Future products designed to dramatically reduce number of interventions required.

MND Diagnostics Ltd.’s detection technology is unique. It breaks the bounds of current technological restraints, being based on the diagnosis of live enzymes in body fluids. This means that infectious disease agents can be detected in their active, reproductive state, in contrast to the techniques of traditional PCR tests. Not only that, but MND”s platform can detect multiple pathogens in a single test. It doesn’t require lab work as the whole test is done in just a few minutes as opposed to several hours in the case of PCR.

Optimata Ltd.A modeling-based biopharmaceutical company, Expert in predictive biosimulation, Optimata mathematically models patient physiological and pathological processes, along with the dynamics of drug-patient interactions, with a special focus on cancer and onc ology drugs.

Oramed PharmaceuticalsOramed Pharmaceuticals (OTC:ORMP.OB) is developing proprietary technology for the oral delivery of drugs presently administered by way of injection. Through its patented flagship product, an oral insulin capsule currently in Phase 2 trials, the Company is seeking to revolutionize the treatment of diabetes.

Pharma Focus IsraelPFC Pharma Focus is a premium International Research Management Organization which brings a new look to the drug development experience by addressing the limitations of conventional study practices. Established in 1992, our professional team has innovative knowledge in modular project management and actual global experience in managing compliant trials, from crafting an effective clinical development plan to a successful study completion.

Pluristem Therapeutics Inc.(NASDAQ: PSTI; DAX: PJT) is a bio-therapeutics company dedicated to the commercialization of allogeneic (non-personalized) cell therapy products for the treatment of a variety of severe degenerative, ischemic and autoimmune disorders where current therapies are unavailable or inadequate.

ProtAbis focused on the development of novel therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune and inflammatory diseases. ProtAb’s therapeutic approach is uniquely based on stimulating a molecule that suppresses inflammation, unlike current drugs on the market which are designed to suppress molecules that stimulate inflammation.

Protalixis a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on the proprietary ProCellEx™ protein expression system. Using the ProCellEx™ system we are developing a pipeline of proprietary recombinant therapeutic proteins based on our plant cell-based expression technology that target large, established pharmaceutical markets and that rely upon known biological mechanisms of action.

Teva Pharmaceutical Industries LTD.is the leading generic pharmaceutical company, marketing products from a wide range of therapeutic areas including cardiovascular, anti-infective, CNS, anti-inflammatory, oncolytic, antidiabetic, analgesic, dermatology, respiratory, and female healthcare. Teva USA has an aggressive Research and Development effort and one of the best overall ANDA approval records in the industry

Advertisements

AICC member Defenition 6 continues growth with four new accounts

May 4, 2009

def61Definition 6, recently won four new clients. Carter’s, Inc., Cox Enterprises, Safeguard Self Storage and Square 1 Art have turned to Definition 6 for its proven experience in redefining brands through the use of online technology.

Atlanta based Definition 6 is the largest independent full-service interactive marketing agency in the Southeast. Combining innovative marketing and ebusiness solutions, ranging from eCommerce and website design to rich media and Web 2.0 technology, with a consultative approach, Definition 6 ensures desired client outcomes are met. With solid infrastructure and web application development expertise, Definition 6 helps bridge the gap between marketing and IT. Definition 6 maintains key partnerships with both Microsoft and Google, and for more than a decade, has generated real business results for clients such as Carter’s, Gables Residential, La Quinta Inn and Suites, NIOXIN Research Laboratories (a Procter & Gamble company) and VeriFone.

Definition 6 joined AICC in 2003. In 2008 the company was a sponsor at AICC’s Web 2.0 Business Exchange.

Full press release


Mazor signs with Scottish Rite Hospital in Atlanta and 2 other US hospitals

April 7, 2009

mazorMazor Surgical Technologies Ltd. (TASE:MZOR) has signed agreements and obtained permits for the installation of its C-Insight 3D surgical imaging system at three US hospitals. The agreements mean that the company has met an important development and marketing milestone for the system.
Mazor is installing C-Insight at three beta sites at the Scottish Rite Hospital in Atlanta, the Florida Campus of the Cleveland Clinic near Miami, and at Newton Wellesley Hospital near Boston. The systems will be used in orthopedic surgical procedures over the coming months.

Mazor Surgical Technologies was founded in 2001, and is dedicated to the research, development, production, marketing and sales of innovative medical devices for surgical procedures. Mazor’s proprietary technology enables a safer surgical environment for patients, surgeons and OR staff, by utilizing miniature robotic, imaging and implant technologies. Mazor’s corporate headquarters is located in Caesarea, Israel and regional offices are located in the Atlanta and Germany. Mazor Joined AICC in 2005 and Nancy Sousa, Mazor’s Chief Operating Oficer is a member of AICC Executive Committee, Board of Directors, and Medical Committee.


AICC and Commissioner Oxendine’s Visit to Escape Rescue (Video by Israel21C)

February 3, 2009

Video by ISRAEL21c

The AICC Mission to Israel delegation in December met with Tel Aviv-based Escape Rescue Systems that has developed a high rise evacuation system that was set to establish a pilot site at an investment of over $1.5 million in Atlanta a few years ago. Georgia Commissioner of Fire Safety and Insurance John Oxendine was in the delegation that received a briefing and demo at their pilot site in Ramat Gan and has met with the company several times since.  Escape Rescue is looking to partner with business owners or government entities to create a full or a scaled down version of the original plan in Atlanta.


AICC Member Mazor Surgical Begins an International Multicenter Clinical Trial

February 1, 2009

mazor1Mazor Surgical Technologies Ltd. has received approval from the ethical committee (Helsinki) of a leading hospital in Israel (Sheba Medical Center) to begin human clinical trial with the Mazor proprietary GO-LIF™ (Guided Oblique Lumbar Interbody Fusion) surgical procedure and implants. This approval allows surgeons to use GO-LIF procedure and Mazor proprietary screws in patients undergoing spinal fixation surgery. Mazor expects this study to demonstrate that the GO-LIF procedure is safe and efficacious leading to improve surgical outcome compared to current procedures. The GO-LIF procedure is an innovative spine surgical procedure developed by Mazor and in partnership with the Cleveland Clinic Foundation, according to the strategic agreement signed in April 2008. This procedure enables spinal fixation by insertion of proprietary GO-LIF implants into the patient’s spine in a minimally invasive surgical technique and accurate guidance enabled by SpineAssist®, Mazor’s miniature robotic device. The GO-LIF clinical study will include additional surgeons and hospitals in 8 medical centers in Israel, Germany and later on in the US, pending additional Helsinki and IRB approvals.

Mazor Surgical Technologies was founded in 2001, and is dedicated to the research, development, production, marketing and sales of innovative medical devices for surgical procedures. Mazor’s proprietary technology enables a safer surgical environment for patients, surgeons and OR staff, by utilizing miniature robotic, imaging and implant technologies. Mazor’s corporate headquarters is located in Caesarea, Israel and regional offices are located in the Atlanta and Germany. Mazor Joined AICC in 2005 and Nancy Sousa, Mazor’s Chief Operating Oficer is a member of AICC Executive Committee, Board of Directors, and Medical Committee.


INN Coverage of AICC Mission to Israel

December 17, 2008

Atlanta Business Execs ‘Rescued’ in Search for New Companies
by Hana Levi Julian
IsraelNN.com

A group of Atlanta business executives was “rescued’ from a high-rise building on Sunday as part of their week-long itinerary of meetings with counterparts in the fields of energy, biotechnology, water technology and communications to discuss joint economic development opportunities — despite the recent fiscal downturn.

Tom Glaser, president of the Atlanta-based American-Israel Chamber of Commerce, Southeast Region (AICC) said in a statement to the media that his group also planned to focus on picking up ties with new Israeli start-ups.”Israeli companies have a strong record of success in Georgia,” he said. The delegation is holding seminars and meetings in Raanana – Atlanta’s official Sister City, and in Yokneam, Atlanta’s Jewish Partnership community, as well as in Herzliya.

The group is checking out business opportunities with Shai Agassi’s “Project Better Place”, among others. They are also meeting with telemedicine companies throughout the country, including at the Galil Center for Telemedicine at the Technion, in order to promote the US-Israel TeleHealth Business Exchange that will be held in Atlanta in February.

Preparing for the Next 9/11
One particular focus of interest by the group has been a Ramat Gan-based company that specializes in getting people out of high buildings in as little time as possible. The “Escape Rescue System” carried out a simulation on Sunday that “stranded” the delegation on the 14th floor of a high-rise building. Within eight minutes, emergency rescue personnel had safely evacuated the entire group. According to company CEO Yoni Shimshoni, the multi-tiered, external evacuation platform system has been designated by the United States Department of Homeland Security as a Qualified Anti-Terrorism Technology. It provides unprecedented fight and flight capabilities in the event of an emergency in a high-rise building and in a full, 5-cabin configuration, the system can deliver up to 25 SWAT personnel and rescue 150 people every 8 minutes.Shimshoni said Atlanta officials have been interested in his system for some time. “We are pleased to have had this opportunity to demonstrate the effectiveness of the system to the Georgia delegation,” he said.

“The tragic events in Mumbai and the changed skyline of New York are reminders of the pride we have in our cities and of the necessity to prepare for another 9/11, a fire or a terrorist hostage-taking situation,” said John Oxendine, Insurance and Safety Fire Commissioner of Georgia, who was present for the simulation. “With more than 200 tall buildings in Atlanta, we need to consider revolutionary rescue and evacuation solutions,” he said.

Home to more than 50 Israeli companies, the state of Georgia is a leading center in the US for Israeli company activity. It has become a popular strategic business destination due primarily to its strong business environment, logistics, human capital and low cost of doing business. The delegation’s visit to Israel, facilitated by the AICC, is part of the state’s effort to entice Israeli businesses to open their U.S. offices in Atlanta and elsewhere throughout the state.


Mueller Water Products, Inc. Joins AICC

December 1, 2008

Mueller Water Products, Inc.  (NYSE: MWA) based in Atlanta Mueller Water Products is a leading North American manufacturer and marketer of a broad range of water infrastructure and flow control products for use in water distribution networks and treatment facilities. Mueller Water Products also acts as a distributor, especially in Canada, for products that are manufactured by other companies. Mueller Water Products broad product portfolio includes engineered valves, hydrants, pipe fittings and ductile iron pipe, which are used by municipalities, as well as the commercial and residential construction, oil and gas, heating, ventilation and air conditioning (“HVAC”) and fire protection industries. Our products enjoy leading market positions due to their broad brand recognition and a reputation for quality and service within the markets we serve. We believe we have one of the largest installed bases of iron gate valves and fire hydrants in the United States, and, as of September 30, 2007, our installed products included approximately three million fire hydrants and approximately nine million iron gate valves. Because of the strength of our brands and products, our products are specified for use in all of the top 50 metropolitan areas in the United States. Mueller Water Products large installed base, broad product range and well-known brands have led to long-standing relationships with the key distributors in the industry. Mueller Water Products diverse end markets, extensive distributor and end-user relationships, acquisition strategy and leading market position have contributed to strong operating margins and sales growth.

Marietta (Martie) Edmunds Zakas has been Senior Vice President, Strategic Planning and Investor Relations, since November 2006. Before joining the Company, from September 2001 through August 2006, Ms. Zakas served in various positions at Russell Corporation, an athletic apparel, footwear and equipment company, culminating in her role as corporate vice president, chief of staff, business development and treasurer. Prior to joining Russell Corporation in 2001, Ms. Zakas served as corporate vice president, director of investor relations and corporate secretary for Equifax, Inc., a consumer and commercial credit reporting agency, from 1993 to 2000. Ms. Zakas also served as Equifax’s treasurer, as well as executive assistant to the Chairman and CEO. Ms. Zakas earned a Bachelor’s Degree from Randolph-Macon Woman’s College, a Master’s of Business Administration from the Colgate-Darden Graduate School of Business Administration at the University of Virginia, and a Juris Doctor from the University of Virginia School of Law.


  • September 2017
    M T W T F S S
    « Aug    
     123
    45678910
    11121314151617
    18192021222324
    252627282930  
  • Accel AICC Board Alliancesphere Amdocs at&t Atlanta Atlanta Business Chronicle Benchmark BlogTV Business Exchange Cellcom Celltick Cisco CleanTech Comverse Deals Eagle Star earnix Escape Rescue Fring Funding GDEcD GeorgiaPower Given Imaging GSMA Harmonic Headquarters HP ICQ IDB IMA Infogin Innovid Israeli Companies Israeli Companies in SE jacada Jeff Pulver Jon Medved Kayote Networks Ken Stewart Lorin Coles M&A maggie bellville Mazor Medical Committee Medtronic members Mission Mobile Monday MobiMate Motorola My6Sense Oxendine PerSay PLYmedia Project Better Place Red Herring Scopus Security Committee SemantiNet Sequoia SIT Software Committee Telecommunications Committee telehealth Texas Instruments Microsoft TodaCell Veritas Vringo Water WorldMate Yokneam-Megiddo Yossi Vardi YouTube Zohar Zisapel